Detailed answers about NEUROBIONICS U.K. LTD, including incorporation, status, business activity, and accounts information.
When was NEUROBIONICS U.K. LTD founded?
NEUROBIONICS U.K. LTD was officially incorporated on 20 October 2026 and is registered under company number 17531241. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is NEUROBIONICS U.K. LTD?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of NEUROBIONICS U.K. LTD?
NEUROBIONICS U.K. LTD's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does NEUROBIONICS U.K. LTD do?
NEUROBIONICS U.K. LTD operates in the following sectors: 26600 - Manufacture of irradiation, electromedical and electrotherapeutic equipment, 72190 - Other research and experimental development on natural sciences and engineering, 74909 - Other professional, scientific and technical activities n.e.c., 82990 - Other business support service activities n.e.c.. These SIC codes provide insight into the company's business activities and industry focus.
What is NEUROBIONICS U.K. LTD's registered address?
The registered office address of NEUROBIONICS U.K. LTD is Squires House, 205a High Street, West Wickham, Kent, United Kingdom, BR4 0PH. This is the official address filed with Companies House for legal and statutory correspondence.
Is NEUROBIONICS U.K. LTD financially stable?
Financial accounts for NEUROBIONICS U.K. LTD are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.